Pharmafile Logo
Pharmafocus logo
Advanced Search

non-Hodgkin lymphoma

Showing 5 posts of 5 posts found.

kitepharma_fullcolor_rgb_1

Kite Pharma climbs on strong data showing in lymphoma trial

March 1, 2017
Research and Development kite pharma, non-Hodgkin lymphoma

Kite Pharma released the news on Rare Diseases Day promising top-line data from a Phase 1/2 trial of its treatment …

News
money_pills_2

Phase II failure sees stock plunge and job cutbacks for Infinity Pharmaceuticals

June 15, 2016
Research and Development, Sales and Marketing AbbVie, infinity pharmaceuticals, non-Hodgkin lymphoma, trial failure

Shares at Infinity Pharmaceuticals (NASDAQ: INFI) fell around 70% upon the announcement of new Phase II data for their non-Hodgkin …

News

Kite Pharma, Roche to co-develop two new treatments for non-hodgkin lymphoma

March 18, 2016
Medical Communications, Research and Development Gentech, Roche, kite pharma, non-Hodgkin lymphoma

Kite Pharma (Nasdaq: KITE) said it will collaborate with Swiss drug major Roche (SIX: ROG) to evaluate the safety and efficacy …

News
FDA image

Spectrum wins FDA approval for rare cancer drug

July 4, 2014
Research and Development, Sales and Marketing Beleodaq, Cancer, FDA, Spectrum, non-Hodgkin lymphoma

In an expedited review the FDA has approved a new cancer drug from Spectrum Pharmaceuticals to treat a rare cancer …

News
GSK logo

GSK’s Arzerra fails in lymphoma

May 21, 2014
Research and Development, Sales and Marketing Arzerra, GSK, Genmab, non-Hodgkin lymphoma

News

Latest content

Prism BioLab and Ono Pharmaceutical enter joint research and licensing agreement

April 25, 2024

Ascendis Pharma’s Yorvipath approved by MHRA for hypoparathyroidism treatment

April 25, 2024

Eli Lilly acquires new manufacturing facility from Nexus Pharmaceuticals

April 24, 2024

GSK’s Jemperli accepted for FDA review for endometrial cancer treatment

April 24, 2024

Sanofi shares results for phase 3 LUNA 3 trial in immune thrombocytopenia

April 23, 2024